Pershia Samadi Selected Research

Ro 61-8048

1/2010	Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
6/2009	Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesias.
7/2005	Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pershia Samadi Research Topics

Disease

21	Dyskinesias (Dyskinesia) 10/2013 - 12/2003
14	Parkinson Disease (Parkinson's Disease) 07/2014 - 07/2005
6	Parkinsonian Disorders (Parkinsonism) 01/2019 - 12/2003
2	Tauopathies 01/2019 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 01/2015
2	Huntington Disease (Huntington's Disease) 01/2015 - 01/2013
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	MPTP Poisoning 08/2005
1	Catalepsy 05/2002

Drug/Important Bio-Agent (IBA)

22	Levodopa (L Dopa)FDA LinkGeneric 10/2013 - 12/2003
16	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2019 - 12/2003
5	Dopamine (Intropin)FDA LinkGeneric 07/2014 - 10/2006
4	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 05/2010 - 02/2008
4	N-Methylaspartate (NMDA)IBA 04/2010 - 07/2004
4	Dopamine Agents (Dopaminergic Agents)IBA 04/2010 - 12/2003
4	Naltrexone (ReVia)FDA LinkGeneric 01/2010 - 12/2003
4	Kynurenine 3-Monooxygenase (Kynurenine 3 Monooxygenase)IBA 01/2010 - 07/2005
3	Messenger RNA (mRNA)IBA 01/2013 - 10/2009
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2010 - 07/2004
3	Cabergoline FDA LinkGeneric 04/2010 - 07/2004
3	besonprodilIBA 04/2010 - 06/2009
3	Docosahexaenoic AcidsIBA 01/2010 - 02/2006
3	Ro 61-8048IBA 01/2010 - 07/2005
3	Opioid Analgesics (Opioids)IBA 10/2006 - 05/2002
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2015
2	EnkephalinsIBA 07/2014 - 01/2013
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 04/2010 - 07/2004
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2010 - 02/2006
2	Pharmaceutical PreparationsIBA 01/2010 - 08/2005
2	preproenkephalinIBA 07/2004 - 06/2004
2	Morphine (MS Contin)FDA LinkGeneric 06/2004 - 05/2002
2	Naloxone (Narcan)FDA LinkGeneric 12/2003 - 05/2002
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019
1	CalcineurinIBA 01/2015
1	polyglutamineIBA 01/2015
1	tau Proteins (tau Protein)IBA 01/2015
1	Serotonin (5 Hydroxytryptamine)IBA 10/2013
1	Huntingtin ProteinIBA 01/2013
1	Glycogen Synthase Kinase 3 betaIBA 04/2010
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2010
1	Excitatory Amino Acid AntagonistsIBA 01/2010
1	Tuberculin (PPD)IBA 01/2010
1	NeuropeptidesIBA 01/2010
1	sarizotanIBA 07/2009
1	4-phenyl-1,2,3,6-tetrahydropyridineIBA 06/2009
1	BenserazideIBA 06/2009
1	Glutamate Receptors (Glutamate Receptor)IBA 06/2009
1	Ro 25-6981IBA 06/2009
1	LY 341495IBA 04/2009
1	metabotropic glutamate receptor 2IBA 04/2009
1	Narcotic Antagonists (Opioid Antagonists)IBA 08/2005
1	Adenosine (Adenocard)FDA LinkGeneric 07/2004
1	GABA-A Receptors (GABA(A) Receptor)IBA 07/2004
1	Glutamic Acid (Glutamate)FDA Link 07/2004
1	Cholinergic ReceptorsIBA 05/2002
1	MecamylamineIBA 05/2002
1	Nicotine FDA Link 05/2002
1	Atropine FDA LinkGeneric 05/2002
1	Hexamethonium (Hexamethonium Bromide)IBA 05/2002

Therapy/Procedure

3	Therapeutics 04/2010 - 02/2008
3	Denervation 01/2010 - 10/2006